Guizhou Xinbang Pharmaceutical Co Ltd Class A 002390
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 28.18
- Price/Sales
- 1.03
- Dividend Yield (Trailing)
- 1.76%
- Dividend Yield (Forward)
- 1.76%
- Total Yield
- 1.76%
Company Profile
Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,149
- Website
- http://www.xinbang.com
Comparables
Valuation
|
Metric
|
002390
|
600422
|
300436
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.18 | 28.32 | — |
Price/Book Value | 0.97 | 2.07 | 6.66 |
Price/Sales | 1.03 | 1.47 | 6.90 |
Price/Cash Flow | 9.96 | 14.27 | — |
Price/Earnings
002390
600422
300436
Financial Strength
|
Metric
|
002390
|
600422
|
300436
|
|---|---|---|---|
Quick Ratio | 2.15 | 1.38 | 0.38 |
Current Ratio | 2.77 | 1.88 | 0.77 |
Interest Coverage | 12.15 | 33.20 | −4.11 |
Quick Ratio
002390
600422
300436
Profitability
|
Metric
|
002390
|
600422
|
300436
|
|---|---|---|---|
Return on Assets (Normalized) | 2.45% | 3.33% | −15.51% |
Return on Equity (Normalized) | 3.33% | 6.05% | −44.17% |
Return on Invested Capital (Normalized) | 3.03% | 5.18% | −20.90% |
Return on Assets
002390
600422
300436
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hvqbchjbg | Xmnc | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Mpbpxfrjv | Hpdsnb | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Pprrhnc | Kck | $48.4 Bil | |||
| Viatris Inc
VTRS
| Thfpzvsy | Pdjt | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Wkcxlmkz | Xddg | $13.5 Bil | |||
| Catalent Inc
CTLT
| Plxyctqms | Qlzkx | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Jbgygyfh | Gshkpz | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Dscvkzhvy | Tvsc | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Tfwxfcvfzl | Dtqzz | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ksgfqmgb | Rdm | $2.3 Bil |
United States